Dose-dependent mechanisms relate to nasal tolerance induction and protection against experimental autoimmune encephalomyelitis in Lewis rats

Immunology

Volumn 94, Issue 3, 1998, Pages 431-437

  Li, H L ^a   Liu, J Q ^a   Bai, X F ^a   Van Der Meide, P H ^b   Link, H ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ARTICLE; IMMUNOLOGICAL TOLERANCE; NONHUMAN; NOSE MUCOSA; PRIORITY JOURNAL; RAT; T LYMPHOCYTE ACTIVATION;

ADMINISTRATION, INTRANASAL; ADOPTIVE TRANSFER; ANIMALS; CATTLE; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; DRUG ADMINISTRATION SCHEDULE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; GUINEA PIGS; IMMUNE TOLERANCE; IN SITU HYBRIDIZATION; INTERFERON TYPE II; INTERLEUKIN-4; LYMPH NODES; MYELIN BASIC PROTEINS; RATS; RATS, INBRED LEW; RNA, MESSENGER; SPECIES SPECIFICITY; T-LYMPHOCYTES;

EID: 0031818742     PISSN: 00192805     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2567.1998.00526.x     Document Type: Article

References (48)

1. WEINER H.L., FRIEDMAN A., MILLER A. et al. (1994) Oral tolerence: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Annu Rev Immunol 12, 809.
2. STEINMAN L. (1996) A few autoreactive cells in an autoimmune infiltrate control a vast population of nonspecific cells: A tale of smart bombs and the infantry. Proc Natl Acad Sci USA 93, 2253.
3. WEINER H.L. (1997) Oral tolerance: immune mechanisms and treatment of autoimmune diseases. Immunol Today 18, 335.
4. CHEN Y., INOBE J.-I., MARKS R., GONNELLA P., KUCHROO V.K. & WEINER H.L. (1995) Peripheral deletion of antigen-reactive T cells in oral tolerance. Nature 376, 177.
5. WHITACRE C.C., GIENAPP I.E., OROSZ C.G. & BITMAR D.M. (1991) Oral tolerance in experimental autoimmune encephalomyelitis HE Evidence for clonal anergy. J Immunol 147, 2155.
6. FRIEDMAN A. & WEINER H.L. (1994) Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc Natl Acad Sci USA 91, 6688.
7. JAVED N.H., GIENAPP I.E., COX K.L. & WHITACRE C.C. (1995) Exquisite peptide specificity of oral tolerance in experimental autoimmune encephalomyelitis. J Immunol 155, 1599.
8. MELAMED D. & FRIEDMAN A. (1993) Direct evidence for anergy in T lymphocytes tolerized by oral administration of ovalbumin. Eur J Immunol 23, 935.
9. MILLER A., LIDER O. & WEINER H.L. (1991) Antigen-driven bystander suppression after oral administration of antigens. J Exp Med 174, 791.
10. MILLER A., LIDER O., ABRAMSKY O. & WEINER H.L. (1994) Orally administered myelin basic protein in neonates primes for immune responses and enhances experimental autoimmune encephalomyelitis in adult animals. Eur J Immunol 24, 1026.
11. WRAITH D.C. (1996) Antigen-specific immunotherapy of autoimmune disease: a commentary. Clin Exp Immunol 103, 349.
12. HOYNE G.F. & LAMB J.R. (1997) Regulation of T cell function in mucosal tolerance. Immunol Cell Biol 75, 197.
13. HOYNE G.F., O'HEHIR R.E., WRAITH D.C., THOMAS W.R. & LAMB J.R. (1993) Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the Dominant T cell epitope in naive and sensitized mice. J Exp Med 178, 1783.
14. HOYNE G.F., CALLOW M.G., KUO M.-C. & THOMAS W.R. (1994) Inhibition of T cell responses by feeding peptides containing major and cryptic epitopes. Studies with the Der pl allergen. Immunology 83, 190.
15. HOYNE G.F., ASKONAS B.A., HETZEL C., THOMAS W.R. & LAMB J.R. (1996) Regulation of house dust mite responses by intranasally administered peptide: transient activation of CD4+ T cells precedes the development of tolerance in vivo. Int Immunol 8, 335.
16. METZLER B. & WRAITH D.C. (1993) Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: inhibition of MHC binding affinity. Int Immunol 5, 1159.
17. DICK A.D., CHENG Y.F., MCKINNON A., LIVERSIDGE J. & FORRESTER J.V. (1993) Nasal administration of retinal antigens suppresses the inflammatory response in experimental allergic uvcoretinitis. A preliminary report of intranasal induction of tolerance with retinal antigens. Br J Ophthalmol 77, 171.
18. MA C.G., ZHANG G.X., XIAO B.G., LINK J., OLSSON T. & LINK H. (1995) Suppression of experimental autoimmune mysathenia gravis by nasal administration of acctylcholine receptor. J Neuroimmunol 58, 51.
19. STAINES N.A., HARPER N., WARD F.J., MALMSTRÖM V., HOLMDAHL R. & BANSAL S. (1996) Mucosal tolerance and suppression of collagen-induced arthritis (CIA) induced by nasal inhalation of synthetic peptide 184 of bovine type II collagen (CII) expressing a dominant T cell epilope. Clin Exp Immunol 103, 368.
20. TIAN J., ATKINSON M.A., CLARE-SALZLER M. et al. (1996) Nasal administration of Glutamate Decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependent diabetes. J Exp Med 183, 1561.
21. + T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. J Exp Med 178, 889.
22. HARRISON L.C., DEMPSEY-COLLIER M., KRAMER D.R. & TAKAHASHI K. (1996) Aerosol insulin induces regulatory CD8 γδ T cells that prevent murine insulin-dependent diabetes. J Exp Med 184, 2167.
23. MA C.-G., ZHANG G.-X., XIAO B.G. et al. (1996) Mucosal tolerance to experimental autoimmune myasthenia gravis is associated with down-regulation of AChR-specific IFN-γ-expressing Th1-like cells and up-regulation of TGF-β mRNA in mononuclear cells. Annu N Y Acad Sci 1996, 273.
24. AL-SABBAGH A., NELSION P.A., AKSELBAND Y., SOBEL R.A. & WEINER H.L. (1996) Antigen-driven peripheral immune tolerance: Suppression of experimental autoimmune encephalomyelitis and collagen-induced arthritis by aerosol administration of myelin basic arthritis by aerosol administration of myelin basic protein or type II collagen. Cell Immunol 171, 111.
25. BAI X.F., SHI F.D., XIAO B.G., LI H.L., VAN DER MEIDE P.H. & LINK H. (1997) Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-β mRNA. J Neuroimmunol 80, 65.
26. DEIBLER G.E., MARTENSSON R.E. & KIES M.W. (1972) Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species. Prep Biochem 2, 139.
27. LINDSTÖM J., EINARSON B. & TZARTOS S. (1981) Production and assay of antibodies to acetylcholine receptors. Meth Enzymol 74, 432.
28. LINK H., OLSSON O., SUN J.-B. et al. (1991) Acetylcholine receptor-reactive T and B cells in myasthenia gravis and controls. J Clin Invest 87, 2191.
29. LINK J., FREDRIKSON S., SÖDERSTRÖM M. et al. (1994) Organ-specific autoantigens induce transforming growth factor-β mRNA expression in mononuclear cells in multiple sclerosis and myasthenia gravis. Ann Neurol 35, 197.
30. WANG Z.Y., LINK, H., LJUNGDAHL Å. et al. (1994) Induction of IFN-γ, IL-4 and TGF-β in rats orally tolerized against experimental autoimmune myasthenia gravis. Cell Immunol 157, 353.
31. KUPER C.F., KOORNSTRA P.J., HAMELEERS D.M.H. et al. (1992) The role of nasopharyngeal lymphoid tissue. Immunol Today 13, 219.
32. SMINIA T., VAN DER BRUGGE-GAMELKOORN G.J. & JEURISSEN S.H. (1989) Structure and function of bronchus-associated tissue (BALT). Crit Rev Immunol 9, 119.
33. HOLT P.G. & MCMENAMIN C. (1989) Defence against allergic sensitization in the healthy lung: the role of inhalation tolerance. Clin Exp Allergy 19, 255.
34. DANIEL D. & WEGMANN D.R. (1996) Protection of nonobese diabetic mice from diabetes by intranasal or subcutaneous administration of insulin peptide B-(9). Proc Natl Acad Sci USA 93, 956.
35. BITAR D.M. & WHITACRE C.C. (1988) Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein. Cell Immunol 112, 364.
36. HIGGINS P. & WEINER H.L. (1988) Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments. J Immunol 140, 440.
37. LIDER O., SANTOS L.M.B., LEE C.S.Y., HIGGINS P.J. & WEINER H.L. (1989) Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes. J Immunol 142, 748.
38. MILLER A., AL-SABBAGH A., SANTOS L.M.B., DAS M.P. & WEINER H.L. (1993) Epitopes of myelin basic protein that trigger TGF-β release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression. J Immunol 151, 7307.
39. MILLER A., LIDER O., ROBERTS A.B., SPORN M.B. & WEINER H.L. (1992) Suppressor T cell generated by oral tolerization to myelin basic protein suppress both in vitro and in vivo immune responses by the release of transforming growth factor β after antigen-specific trigerring. Proc Natt Acad Sci USA 89, 421.
40. KHOURY S.J., HANCOCK W.W. & WEINER H.L. (1992) Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor beta, interleukin 4, and prostaglandin F. expression in the brain. J Exp Med 176, 1355.
41. BROCKE S., GUBELS K., ALLEGRETTA M. et al. (1996) Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379, 343.
42. RACKE M.K., BONOMO A., SCOTT D.E. et al. (1994) Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180, 1961.
43. RÖCKEN M., RACKE M. & SHEVACH E.M. (1996) IL-4-induced immune deviation as antigen-specific therapy for inflammatory autoimmune disease. Immunol Today 17, 255.
44. SCHLUESENER H.J. & LIDER O. (1989) Transforming growth factors b1 and b2: cytokines with identical immnosuppressive effects and a potential role in the regulation of autoimmune T cell function. J Neuroimmunol 24, 249.
45. FABRY Z, TOPHAM D.J., FEE D. et al. (1995) TGF-β2 decreases migration of lymphocytes in vitro and homing of cells into the central nervous system in viva. J Immunol 155, 325.
46. KENNEDY M.K., TORRANCE D.S., PICHA K.S. & MOHLER K.M. (1992) Analysis of cytokine mRNA expression in the central nervous system of mice with experimental autoimmune encephalomyelitis reveals that IL-10 mRNA expression correlates with recovery. J Immunol 149, 2496.
47. ROTT O., FLEISCHER B. & CASH E. (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur J Immunol 24, 1434.
48. CANNELA R., GAO Y.L., BROSNAN C. & RAINE C.S. (1996) IL-10 fails to abrogate experimental autoimmune encephalomyelitis. J Neurosci Res 45, 735.